Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Cristina Pirosa

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Hematological Oncology|June 9, 2023
Lymphomas in pregnancyMaria Cristina Pirosa, Fedro Alessandro Peccatori
Current Oncology Reports|February 5, 2019
BET and EZH2 Inhibitors: Novel Approaches for Targeting CancerSofia Genta, Maria Cristina Pirosa, Anastasios Stathis
Human Vaccines & Immunotherapeutics|February 1, 2024
Tafasitamab for the treatment of patients with diffuse large B-cell lymphomaMaria Cristina Pirosa, Anastasios Stathis, Emanuele Zucca
Clinical Lymphoma, Myeloma & Leukemia|March 7, 2025
SOHO State of the Art Updates and Next Questions: Treatment Options for Marginal Zone LymphomaMaria Cristina Pirosa, Anastasios Stathis, Davide Rossi, et al.
Hemasphere|June 24, 2022
Controversies in the Interpretation of Liquid Biopsy Data in LymphomaMaria Cristina Pirosa, Sven Borchmann, Fabrice Jardin, et al.
Current Opinion in Oncology|July 26, 2022
Bacterial infection-driven lymphomagenesisBarbara Vannata, Maria Cristina Pirosa, Francesco Bertoni, et al.
British Journal of Haematology|August 18, 2020
Prognostic value of POD24 validation in follicular lymphoma patients initially treated with chemotherapy-free regimens in a pooled analysis of three randomized trials of the Swiss Group for Clinical Cancer Research (SAKK)Alden Alberto Moccia, Sämi Schär, Stefanie Hayoz, et al.
La Radiologia Medica|September 26, 2023
CT-based body composition in diffuse large B cell lymphoma patients: changes after treatment and association with survivalMaria Cristina Pirosa, Fabiana Esposito, Giorgio Raia, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 17, 2025
PET-Based Risk Stratification in Primary Mediastinal B-Cell Lymphoma: A Comparative Analysis of Different Segmentation Methods in the IELSG37 Trial Patient CohortLuca Ceriani, Lisa Milan, Maria Cristina Pirosa, et al.
British Journal of Haematology|August 7, 2019
Late relapse in patients with diffuse large B-cell lymphoma: impact of rituximab on their incidence and outcomeBarbara Vannata, Annarita Conconi, Jonas Winkler, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Hematological Oncology|June 9, 2023
Lymphomas in pregnancyMaria Cristina Pirosa, Fedro Alessandro Peccatori
Current Oncology Reports|February 5, 2019
BET and EZH2 Inhibitors: Novel Approaches for Targeting CancerSofia Genta, Maria Cristina Pirosa, Anastasios Stathis
Human Vaccines & Immunotherapeutics|February 1, 2024
Tafasitamab for the treatment of patients with diffuse large B-cell lymphomaMaria Cristina Pirosa, Anastasios Stathis, Emanuele Zucca
Clinical Lymphoma, Myeloma & Leukemia|March 7, 2025
SOHO State of the Art Updates and Next Questions: Treatment Options for Marginal Zone LymphomaMaria Cristina Pirosa, Anastasios Stathis, Davide Rossi, et al.
Hemasphere|June 24, 2022
Controversies in the Interpretation of Liquid Biopsy Data in LymphomaMaria Cristina Pirosa, Sven Borchmann, Fabrice Jardin, et al.
Current Opinion in Oncology|July 26, 2022
Bacterial infection-driven lymphomagenesisBarbara Vannata, Maria Cristina Pirosa, Francesco Bertoni, et al.
British Journal of Haematology|August 18, 2020
Prognostic value of POD24 validation in follicular lymphoma patients initially treated with chemotherapy-free regimens in a pooled analysis of three randomized trials of the Swiss Group for Clinical Cancer Research (SAKK)Alden Alberto Moccia, Sämi Schär, Stefanie Hayoz, et al.
La Radiologia Medica|September 26, 2023
CT-based body composition in diffuse large B cell lymphoma patients: changes after treatment and association with survivalMaria Cristina Pirosa, Fabiana Esposito, Giorgio Raia, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 17, 2025
PET-Based Risk Stratification in Primary Mediastinal B-Cell Lymphoma: A Comparative Analysis of Different Segmentation Methods in the IELSG37 Trial Patient CohortLuca Ceriani, Lisa Milan, Maria Cristina Pirosa, et al.
British Journal of Haematology|August 7, 2019
Late relapse in patients with diffuse large B-cell lymphoma: impact of rituximab on their incidence and outcomeBarbara Vannata, Annarita Conconi, Jonas Winkler, et al.
Pageof 4